These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17882786)

  • 1. Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). New data on treatment-experienced patients and drug resistance.
    Lucas GM
    Hopkins HIV Rep; 2007 Mar; 19(2):4-6. PubMed ID: 17882786
    [No Abstract]   [Full Text] [Related]  

  • 2. Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). Management of treatment-naïve patients.
    Gallant JE
    Hopkins HIV Rep; 2007 Mar; 19(2):1-3, 12. PubMed ID: 17882785
    [No Abstract]   [Full Text] [Related]  

  • 3. Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). Viral hepatitis co-infection in HIV.
    Gebo K; Wilson L
    Hopkins HIV Rep; 2007 Mar; 19(2):7-9. PubMed ID: 17882787
    [No Abstract]   [Full Text] [Related]  

  • 4. 14th annual retrovirus conference (CROI). New drugs at CROI: the four musketeers. New drugs new targets, new hope.
    Berry J
    Posit Aware; 2007; 18(3):21-3. PubMed ID: 17526109
    [No Abstract]   [Full Text] [Related]  

  • 5. Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). CD4 lymphocyte depletion: where have all the cells gone?
    Kim S; Blankson JN
    Hopkins HIV Rep; 2007 Mar; 19(2):10-2. PubMed ID: 17882788
    [No Abstract]   [Full Text] [Related]  

  • 6. 14th annual retrovirus conference (CROI). One-on-one with Joseph J. Eron, MD. Interview by Jeff Berry.
    Eron JJ
    Posit Aware; 2007; 18(3):31-3. PubMed ID: 17526114
    [No Abstract]   [Full Text] [Related]  

  • 7. A report from the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 (February 23-26--Seattle, Washington, USA).
    Rabasseda X
    Drugs Today (Barc); 2015 Mar; 51(3):209-16. PubMed ID: 25876564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report from the 11th conference on retroviruses and opportunistic infections. STI.
    del Rio C
    AIDS Clin Care; 2004 Apr; 16(4):27-8. PubMed ID: 15124582
    [No Abstract]   [Full Text] [Related]  

  • 9. Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). The treatment of experienced patients and resistance mechanisms.
    Lucas GM
    Hopkins HIV Rep; 2004 Mar; 16(2):6-7, 15. PubMed ID: 15119309
    [No Abstract]   [Full Text] [Related]  

  • 10. Report from the 17th Conference on Retroviruses and Opportunistic Infections. CCR5 antagonists--out with the old, in with the new?
    Albrecht H
    J Watch AIDS Clin Care; 2010 Apr; 22(4):32. PubMed ID: 20480620
    [No Abstract]   [Full Text] [Related]  

  • 11. 13th Conference on Retroviruses and Opportunistic Infections (CROI), Denver, USA, 5-8 February 2005.
    Rusconi S
    J HIV Ther; 2006 Mar; 11(1):20-2. PubMed ID: 16706252
    [No Abstract]   [Full Text] [Related]  

  • 12. Highlights of the 6th Conference on Retroviruses and Opportunistic Infections.
    Laurence J
    AIDS Read; 1999; 9(2):80, 83. PubMed ID: 12728887
    [No Abstract]   [Full Text] [Related]  

  • 13. Selected highlights from the 6th Conference on Retroviruses and Opportunistic Infections.
    Bartnof HS
    BETA; 1999 Apr; 12(2):33-52. PubMed ID: 11366695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in antiretroviral therapy.
    Sobieszczyk ME; Jones J; Wilkin T; Hammer SM
    Top HIV Med; 2006; 14(1):36-62. PubMed ID: 16641526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance studies from the 10th Conference on Retroviruses and Opportunistic Infections.
    Boyle BA
    AIDS Read; 2003 Apr; 13(4):166-71. PubMed ID: 12741367
    [No Abstract]   [Full Text] [Related]  

  • 16. Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). Complications/toxicity of HIV therapy.
    Moore RD; Confrancesco J
    Hopkins HIV Rep; 2005 May; 17(3):1-5, 9. PubMed ID: 16419310
    [No Abstract]   [Full Text] [Related]  

  • 17. 12th Conference on Retroviruses and Opportunistic Infections (CROI).
    HIV Clin Trials; 2005; 6(3):169-81. PubMed ID: 16192250
    [No Abstract]   [Full Text] [Related]  

  • 18. Report from the 13th Conference on Retroviruses and Opportunistic Infections (CROI), February 5-8, 2006, Denver, Colorado.
    TreatmentUpdate; 2006; 18(2):4-6. PubMed ID: 17230629
    [No Abstract]   [Full Text] [Related]  

  • 19. Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). The tenacity of NNRTI drug resistance.
    Persaud D; Gallant JE
    Hopkins HIV Rep; 2004 Mar; 16(2):1, 5, 15. PubMed ID: 15119307
    [No Abstract]   [Full Text] [Related]  

  • 20. Rethinking STIs, revamping salvage, revisiting toxicity (or, the clouds of chronicity). 11th conference on retroviruses and opportunistic infections. February 8-11, 2004, San Francisco.
    Mascolini M
    IAPAC Mon; 2004 May; 10(5):154-76. PubMed ID: 15366102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.